TENAX THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
TENAX THERAPEUTICS, INC. (TENX) had Prepaid Expense and Other Assets, Current of $3.44 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2025-11-12
- 2025-09-30: Prepaid Expense and Other Assets, Current $3.44M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $395.00K.
- 2024-12-31: Prepaid Expense and Other Assets, Current $1.83M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2025-09-30 | $3.44M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $395.00K 10-Q · filed 2025-08-13 |
| 2024-12-31 | $1.83M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |